Serum levels of matrix metalloproteinases and tumor necrosis factor-α in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels
- 15 April 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (8) , 1024-1027
- https://doi.org/10.1016/s0002-9149(03)00133-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 2002
- Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathyJournal of the American College of Cardiology, 2001
- A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart FailureCirculation, 2000
- Interleukin-1β and Tumor Necrosis Factor-α Decrease Collagen Synthesis and Increase Matrix Metalloproteinase Activity in Cardiac Fibroblasts In VitroCirculation Research, 2000
- Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodelingCardiovascular Research, 2000
- Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated CardiomyopathyCirculation, 1998
- Increased Plasma Levels of Adrenomedullin in Patients with Hypertrophic Cardiomyopathy: Its Relation to Endothelin-1, Natriuretic Peptides and NoradrenalineClinical Science, 1998
- Differential gene expression of extracellular matrix components in dilated cardiomyopathyJournal of Cellular Biochemistry, 1996
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978